CDE vs REGN · P/E 18, rev $1.05B vs P/E 14, rev $14.34B
Coeur Mining Inc (CDE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Coeur Mining Inc (CDE) is a gold company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported CDE revenue for 2024-12-31 was $1.05B. Net income was $58.9M. Revenue was up 28.3% from 2023-12-31 to 2024-12-31. CDE currently screens at market cap $21.46B and trailing P/E 17.7.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
CDE currently screens at market cap $21.46B and trailing P/E 17.7. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the CDE and REGN stock pages for the full models.
Not investment advice.